Abstract: This medicament, which contains, together or separately in combination with a PARP inhibitor, an antibody or a fragment thereof having an immunological reactivity with a CAPRIN-1 protein, is useful for treating and/or preventing cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202517014372-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [19-02-2025(online)].pdf | 2025-02-19 |
| 2 | 202517014372-STATEMENT OF UNDERTAKING (FORM 3) [19-02-2025(online)].pdf | 2025-02-19 |
| 5 | 202517014372-Sequence Listing in PDF [19-02-2025(online)].pdf | 2025-02-19 |
| 6 | 202517014372-REQUEST FOR EXAMINATION (FORM-18) [19-02-2025(online)].pdf | 2025-02-19 |
| 7 | 202517014372-PROOF OF RIGHT [19-02-2025(online)].pdf | 2025-02-19 |
| 8 | 202517014372-POWER OF AUTHORITY [19-02-2025(online)].pdf | 2025-02-19 |
| 9 | 202517014372-FORM 18 [19-02-2025(online)].pdf | 2025-02-19 |
| 10 | 202517014372-FORM 1 [19-02-2025(online)].pdf | 2025-02-19 |
| 11 | 202517014372-FIGURE OF ABSTRACT [19-02-2025(online)].pdf | 2025-02-19 |
| 12 | 202517014372-DRAWINGS [19-02-2025(online)].pdf | 2025-02-19 |
| 13 | 202517014372-DECLARATION OF INVENTORSHIP (FORM 5) [19-02-2025(online)].pdf | 2025-02-19 |
| 14 | 202517014372-COMPLETE SPECIFICATION [19-02-2025(online)].pdf | 2025-02-19 |
| 15 | 202517014372-certified copy of translation [20-02-2025(online)].pdf | 2025-02-20 |
| 16 | 202517014372-MARKED COPIES OF AMENDEMENTS [22-02-2025(online)].pdf | 2025-02-22 |
| 17 | 202517014372-FORM 13 [22-02-2025(online)].pdf | 2025-02-22 |
| 18 | 202517014372-AMMENDED DOCUMENTS [22-02-2025(online)].pdf | 2025-02-22 |
| 19 | 202517014372-FORM 3 [30-07-2025(online)].pdf | 2025-07-30 |